Hong Kong

The drug discovery platform attracted retail orders for about 107 times the shares initially available.

The latest funding round puts the value of the company at around US$4b.

Its lack of investments in an AI-enabled workforce and analytics infrastructure is weighing on its ambitions.

Its low technology adoption rate is driving up construction costs.

It will provide information and technical support on redeveloping sites to building owners.

Only 47% cited quick and easy banking as their top priority.

Non-Chinese restaurants saw $9.58m in receipts.

Private consumption and investment growth will prop up the struggling economy.

HKMA is setting up a centre for green finance.

Demand will continue to come from companies in the financial sector.

Both firms have been classified as ST Stocks.

Demand for luxury properties may manifest in New Territories and Tung Chung.

Cargo throughput is set to rise to 9 million tonnes by 2030.

Poor performance is not the only reason.

There is an uncertainty in the retail landscape with wildly differing views on where 2019 is headed, as leading economists are writing off 2019 as a bad year for retail whilst other reports stated that retail improved between December and January due only to seasonal factors.

Loans for use inside Hong Kong rose by 1.2%.